Skip to main content

Multi-location (regional) delivery

Coordinated delivery across multiple organisations

Most CRDCs can support studies through multi-location delivery models, including regional networks and hub-and-spoke approaches, where multiple organisations work together to deliver a single study.

These flexible models enable studies to be delivered at scale across large geographical areas, healthcare settings and diverse populations. These models allow research to be brought to the patient, reducing the travel burden which has historically been part of commercial trial participation.

How the model works

  • Research activity is coordinated across a network of participating organisations
  • A lead organisation may provide overall coordination, oversight and specialist expertise, where appropriate
  • Participating sites can deliver study activities across primary, secondary, specialist or community care settings
  • One organisation may hold the Clinical Trial Agreement (CTA) with the study sponsor, and coordinate study delivery on behalf of the network
  • Sites can undertake different study activities according to local capabilities and study requirements, and in some cases may operate as standalone delivery sites

Why this model is used

This approach supports:

  • Recruitment at scale and pace
  • Consistent study delivery across multiple locations
  • Access to broader and more diverse patient populations, through a single contract
  • Integration of research into routine care pathways
  • Greater accessibility to research opportunities for patients and communities

Support from the Network

The CRDC UK Network supports sponsors to:

  • Identify when a multi-location model is appropriate
  • Navigate delivery across organisations
  • Coordinate engagement and implementation

We provide practical support and coordination throughout, helping sponsors work through this model with confidence.

Contact us

CRDC UK Network news

07 July 2026

CRDC UK Network supports Kailera Therapeutics to bring its first studies to the UK

21 research centres across the UK will support three flagship obesity studies for Kailera Therapeutics supported by the CRDC UK Network. The participating centres are pre...

18 June 2026

CRDC UK Network Director awarded Damehood in King’s Birthday Honours List

World leading type 2 diabetes and obesity expert, Professor Melanie Davies CBEhas become a Dame Commander of the Order of the British Empire (DBE) for services to global ...

23 March 2026

Helping make the UK globally competitive in data-enabled digital trials

The CRDC UK Network is in full support of the ABPI’s new report, published 23 March 2026, ‘Globally competitive UK-wide data-enabled clinical trials: the time...